Kimberly Noonan

Kimberly Noonan is an accomplished professional with a strong background in Clinical Trial Design, Immune Monitoring, Scientific Consulting, Immunotherapies, Immunovaccines, T cell activation, and Multiple Myeloma.

She completed her education in Microbiology/Immunology at the University of Pittsburgh, demonstrating a solid academic foundation in her field.

Kimberly Noonan holds key positions in the industry, currently serving as the EVP, CSO, and Founder at WindMIL Therapeutics, showcasing her leadership and entrepreneurial skills.

Her previous roles include serving as Adjunct Faculty and Research Associate/Faculty at Johns Hopkins University, highlighting her experience in academia and research.

With her expertise and experience, Kimberly Noonan is a valuable asset in the field of immunotherapy and clinical research.